https://doi.org/10.1038/srep24929
M
Mitali Mishra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
72
Papers
1.4K
Citations
18
h-index
27
i10-index
Mitali Mishra is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Computational Drug Discovery Methods & Synthesis and biological activity & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 18, co-authored 62 publications.
ORCID: 0000-0003-1106-7342Papers by this author
worksPolysaccharide-capped silver Nanoparticles inhibit biofilm formation and eliminate multi-drug-resistant bacteria by disrupting bacterial cytoskeleton with reduced cytotoxicity towards mammalian cells
2016 · Scientific Reports · 212 citations
The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
2022 · Science · 169 citations
https://doi.org/10.1126/science.abq5358
A single immunization with intranasal Newcastle disease virus (NDV)-based XBB.1.5 variant vaccine reduces disease and transmission in animals against matched-variant challenge
2024 · Vaccine · 4 citations
https://doi.org/10.1016/j.vaccine.2024.126586
Molecular and serological investigation of the 2021 COVID-19 case surge in Mongolian vaccinees
2021 · medRxiv · 3 citations
https://doi.org/10.1101/2021.08.11.21261915
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat